Human mononuclear cells (MNC) secrete histamine-releasing factor(s) (HRF) when cultured in vitro. HRF induces the release of histamine and other mediators from basophils and mast cells. We have shown that MNC also produce a histamine release inhibitory factor (HRIF), and that the synthesis is augmented by culture with physiologic concentrations of histamine (10-10 to 10' M) and by the mitogen concanavalin A (Con A). HRIF does not affect release initiated by other secretagogues such as allergen, anti-IgE, C5a, Con A, and phorbol myristate acetate. HRIF requires a preincubation with the cells for 5-10 min for maximal inhibition, and this effect is not abolished by washing the cells after the preincubation. The biological activity of HRIF is protease-sensitive, neuraminidase-resistant, and relatively heat-stable. HRIF can be distinguished from HRF by a lower apparent molecular mass (8,000-10,000 D).
Introduction
A complex network of interactions exists between the immunoregulatory cells (lymphocytes and monocytes) and the primary effector cells of allergic reactions (mast cells and basophils). Lymphocytes produce interleukin 3 (IL-3), a pluripotent colony-stimulating factor that stimulates the growth of mast cells and basophils (1) . IL-4 acts as an auxiliary factor in the growth of mast cells (2) . It has been claimed that another cytokine, basophil growth factor, selectively stimulates the growth and differentiation of basophils (3) . Lymphocytes also affect the function of these cells. B cells produce IgE antibodies, which bind to the high-affinity receptors on the surface of the mast cells and basophils and arm them for specific effector function.
Dvorak and his associates (4) were the first to postulate that lymphocytes might directly activate mast cells and basophils in delayed hypersensitivity reactions. Subsequently, it has been shown that mononuclear cells, lymphocytes, and pulmonary macrophages produce histamine-releasing factors (HRF)' that activate human mast cells and basophils with increased di-rected migration and release of histamine and leukotrienes (5) (6) (7) (8) (9) . Another group of lymphokines has been identified in rodents that specifically binds to antigens and releases serotonin from mast cells (10) . Thus, it is apparent that immunoregulatory cells produce a number of substances that stimulate the growth and function of mast cells and basophils.
Analysis of the regulatory mechanisms of the immune system reveals that they often function in a dichotomous fashion. For instance, growth stimulatory factors (e.g., IL-14, colonystimulating factors) are opposed by growth inhibitory cytokines (e.g., soluble immune response suppressor, inhibitor of DNA synthesis, inhibitor ofcolony formation, and inhibitor of IL-2) (11) (12) (13) (14) . The activity of chemotactic factors is abrogated by migration inhibitory factors (15) . The production of IgE is regulated by two opposing factors: IgE potentiating factor and IgE suppressive factor (16) .
These observations support the conclusion that lymphocytic regulation of effector cells comprises two loops: stimulatory and inhibitory. In the case of mast cells and basophils, only the stimulatory loop has been identified. Therefore, we asked whether mononuclear cells (MNC) produce cytokines that inhibit the function of mast cells and basophils. Recently, the production of a histamine release inhibitory factor (HRIF) by guinea pig lymphoid cells has been reported by one of us (17) . This cytokine blocks histamine release from guinea pig mast cells and basophils. The present study was undertaken to investigate whether human lymphocytes produce a similar inhibitory factor.
It is clear that histamine is a major factor in allergic inflammation. This substance also has important immunomodulatory effects. Some of its actions include immunosuppressive effects such as stimulating the synthesis of inhibitory lymphokines (18). Therefore, we investigated whether histamine might stimulate the synthesis of HRIF by human MNC.
cushion. MNC were separated and washed three times with HBSS and suspended at a concentration 5 X 106/ml in RPMI 1640 medium containing 100 U penicillin/ml, 100 Atg streptomycin/ml, 4 mM glutamine, and 5 X 10-6 M 2-mercaptoethanol.
Generation ofHRIF-containing supernatants. MNC were cultured (10 ml ofcell suspension in a 25-cm2 tissue culture flask) in the absence or presence of various concentrations of histamine for 24 h at 370C in a humidified incubator. Supernatants were harvested by centrifugation and extensively dialyzed against sterile water (usually 2 X 1,000 vol) and Hepes buffer, pH 7.4 (10 mM Hepes, 137 mM NaCl, and 5 mM KCI) containing 2 mM CaCI2 and I mM MgCl2 (HCM buffer) to completely remove histamine. Spectrapor dialysis tubing with a M, cutoff of 3,500 D was used for routine dialysis. The dialyzed supernatants were used immediately or stored at -70'C.
Generation ofCon A-conditioned medium and separation ofHRF by gel filtration. Leukocytes were isolated from buffy coats obtained from normal blood bank donors. MNC were isolated as described earlier and pulsed with Con A (25 gg/ml) in RPMI medium for 4 h, washed twice with HBSS, resuspended in RPMI medium, and cultured for 72 h. The supernatants were harvested, dialyzed, and assayed for both HRF and HRIF as described below.
In other experiments supernatant fluid was concentrated X50 by using an ultrafiltration chamber (Amicon Corp., Danvers, MA) with YM-5 filters (mol wt cutoff 5,000). Usually supernatants were pooled from cultured MNC obtained from 10-15 liters of blood and concentrated, and 20-30 ml of this sample was then applied to gel filtration columns (5 X 100 cm) containing Sephadex G-75. Fractions containing histamine-releasing activity (I 5-30-kD fractions), measured as described below, were pooled, concentrated 10-fold, divided into aliquots, frozen at -70°C, and used as a source of HRF.
Isolation ofperipheral blood leukocytes. Venous blood from allergic donors was anticoagulated with 10 mM EDTA and sedimented with 1.5% hydroxyethyl starch for 30 min at room temperature. The leukocyte-rich buffy coat was collected and washed three times in Hepes buffer, pH 7.4 and 0.03% human serum albumin (HA buffer) in a refrigerated centrifuge (4°C) at 300 g. The washed leukocytes (0.1-1% basophils) were suspended in Hepes buffer, pH 7.4, 0.03% human serum albumin, 2 mM CaCl2, and 1 mM MgCl2 (HACM buffer). Leukocytes from 1 ml of blood were usually used for one duplicate experiment for assaying HRF and HRIF.
Assay of HRF. Aliquots of 100 ul of test supernatant were incubated with 100 ,l of leukocyte suspension for 45 min in a shaking water bath at 37°C. Each experiment was done in duplicate. At the end of the incubation, 400 Ml of HA buffer were added to each tube. The supernatants were separated from the cells by centrifugation at 600 g for 5 min at 4°C. The histamine content of the supernatants was measured using an automated fluorometric analyzer (20) . Spontaneous histamine release was assessed by incubating the cells in HACM buffer alone. The total histamine content of the cells was measured by lysing the cells with 3% perchloric acid. The percentage of histamine release was calculated according to the formula: (histamine in the supernatant)/(total histamine in the cells) X 100.
Spontaneous histamine release from the cells was usually < 5% and was subtracted from the calculated histamine release.
Assay ofHRIF. Aliquots of 100 Ml ofdiluted test supernatants were preincubated with 100 Ml of leukocyte suspension for 5 min at 37°C and then challenged with 100 MA of HRF-containing supernatant for an additional 45 min at 37°C. Three sets of controls were run simultaneously: (i) cells preincubated with buffer and then challenged with HRF, (ii) cells preincubated with the test supernatant and then challenged with buffer, and (iii) cells preincubated with buffer and challenged with buffer.
Each experiment was performed in duplicate. At the conclusion of the incubation, 300 Ml of HACM buffer were added to each tube, and the supernatants were separated from the cells by centrifugation at 600 g for 5 min at 4°C. The histamine content of the supernatants was measured spectrofluorometrically (20) . The percentage of histamine released was calculated as described above. ing supernatants from histamine-stimulated MNC cultures were dialyzed against HCM, pH 7.8, and then incubated with trypsin (2 U/ml) or chymotrypsin (2 U/ml) for 2 h at 30'C. Neuraminidase coupled to agarose was washed with acetate buffer, pH 5.0, and then incubated for 2 h at 370C at a concentration of 2 U/ml with HRIF dialyzed against the same buffer. Controls included supernatants treated with the same buffers (positive control) and agarose-coupled enzymes incubated with buffer (negative control). Supernatants were separated from the enzymes by centrifugation, dialyzed against HCM buffer (pH 7.4) and assayed for HRIF.
Affinity chromatography. Aliquots of 1 ml of histamine-or Con A-stimulated supernatants were incubated with 0.5 ml ofwashed lentil lectin-coupled Sepharose for 90 min at room temperature as described by Yodoi et al. (21) . After removal of the effluent and washing with 4 ml of HCM buffer, the beads were eluted with 4 ml of 0.2 M a-methylmannoside at 4°C. For peanut agglutinin-agarose chromatography, aliquots of 1 ml of the supernatants were mixed with 0.15 ml of the washed packed gel at 4°C for 4 h (21). The effluent was removed, and the beads were washed with 4 ml of HCM and then 4 ml of 0.2 M D-galactose in HCM buffer, pH 7.4. All fractions were dialyzed against HCM buffer and then assayed for HRF and HRIF activity.
Statistical analysis. Results are expressed as mean±SEM. Data were analyzed for differences using the computer program EPISTAT.
Results
Effect of histamine on synthesis ofHRF. We have previously reported that human MNC release small amounts of HRF spontaneously. In our preliminary experiments we examined the effect of histamine on this production. Cells from 10 healthy donors were cultured with or without histamine (10-8 M) and unconcentrated supernatants were assayed for histamine release from fresh basophils. The amount of histamine released by supernatants from cell cultured with and without histamine was 3±1% and 9±1%, respectively, and the difference was significant (P < 0.001, Student's t test). We speculated that histamine-stimulated supernatant might contain an inhibitor of histamine release. Therefore, we examined whether the supernatants could inhibit release of histamine from peripheral blood basophils.
Stimulation of HRIF synthesis by histamine. First we in-vestigated the effect on the secretion initiated by HRF. We observed that supernatant from histamine-stimulated MNC inhibited histamine release from heterologous basophils by HRF (Fig. 1) . MNC cultured alone showed modest inhibitory activity, but histamine-stimulated supernatant showed significantly (P < 0.001, Wilcoxon's rank sum test) higher activity. The action of this HRIF obtained from six consecutive cell donors was dose-dependent over a wide range of dilutions. Histamine incubated with medium alone and then dialyzed did not show any inhibitory activity. Histamine was undetectable in all these dialyzed supernatants.
The production of HRIF depended on the dose of histamine used in the culture. The highest production of HRIF was usually noted at a concentration 10-6 to 10-8 M (Fig. 2) , although we observed considerable individual variation.
Over the last 11/2 yr we have examined the production of HRIF by histamine-stimulated MNC obtained from 30 normal donors and obtained significant activity from 80% of the donors in response to at least one concentration of histamine.
Effect ofCon A on both HRF and HRIF. Since Con A is a nonspecific mitogen and stimulates various subpopulations of MNC (e.g., helper and suppressor T cells), we reasoned that Con A-stimulated supernatant might contain both HRF and HRIF activities. Therefore, we assayed net histamine release by unstimulated and Con A-stimulated supernatants obtained from culturing MNC of four normal donors as well as the effect ofthese supernatants on HRF-induced histamine release from basophils. As shown in Fig. 3 Gelfiltration. Gel filtration of histamine-stimulated supernatant revealed a single peak of activity at the Mr range 8-10 kD (Fig. 4 A) . Gel chromatography of Con A-pulsed MNC supernatant (Fig. 4 B) incubated with these enzymes (no HRIF) and then tested, it did not release any histamine from basophils, nor did it affect the response to HRF. HRIF is heat-stable at 560C and fairly resists X4 freezing and thawing. In attempting to separate HRF and HRIF by affinity chromatography using lentil lectin-Sepharose and peanut agglutinin-agarose, we found neither molecule bound to these lectincoupled gels and both activities were recovered from the effluents (data not shown).
A preincubation period of 5-10 min with basophils is necessary for complete inhibitory activity (Fig. 5) . We also studied the effect of removal of HRIF after preincubation upon HRF-induced histamine release from basophils. Leukocytes were preincubated with HRIF for 10 min then centrifuged and washed twice against 40 vol ofbuffer and then challenged with HRF. In six experiments, the inhibition of histamine release was 60±4% which was not significantly different from that released by the unwashed cells (64±3%, P > 0.5, Student's t test).
We wondered whether HRIF binds to HRF in the fluid phase and thereby inhibits histamine release. To address this issue, we preincubated HRIF with HRF for 10 mim and then added cells. There was no inhibition of histamine release in these experiments (n = 6). In contrast, the same batch of HRIF inhibited histamine release by 64±3% when preincubated with basophils for 5 min before the addition of HRF.
Specificity of HRIF. The inhibitory activity of HRIF towards other agonists was also evaluated. Basophils were preincubated with histamine-stimulated supernatants and then challenged with ragweed antigen, anti-IgE, Con A, PMA, and C5a. We found that HRIF did not inhibit histamine release from basophils induced with these agents (Fig. 6 ).
Discussion
The results presented in this paper demonstrate that MNC from healthy subjects produce a HRIF upon stimulation with histamine or the mitogen Con A. HRIF specifically inhibits HRF-induced histamine release from basophils. Other basophil secretagogues-ragweed pollen allergens, anti-IgE, Con A, PMA (a protein kinase C activator), and the anaphylatoxin C5a-are not blocked by HRIF. Inhibition of histamine release by HRIF requires preincubation with basophils for 5 Figure 6 . Effect of HRIF on histamine release by various secretagogues. Basophils from ragweed sensitive donors were preincubated with HRIF-containing supernatant (final dilution of 1:6) for 5 min, then challenged with HRF, ragweed allergen (10-6 wt/vol), anti-IgE (1:10,000), Con A (10 ug/ml), PMA (10 ng/ml), and C5a (1:100).
Results (mean±SEM) from six experiments are shown in the figure.
HRIF significantly inhibited HRF-induced histamine release but failed to affect histamine release by allergen, anti-IgE, Con A, PMA, and C5a. Control histamine release in these experiments ranged from 30% to 60%.
when tested at concentrations in a range of 0.05-500 U/ml (data not shown).
Histamine inhibits antigen-induced histamine release from basophils at concentrations of 3 X l0-7 to 10-6 M (22). We do not think that inhibition of HRF-induced histamine release was due to the presence of contaminating histamine in the supernatant because histamine was undetectable in the dialyzed supernatants (< 10-9 M). Furthermore, HRIF did not inhibit antigen-induced histamine release in our experiments.
One of the major problems that we encountered in assaying HRIF was the presence of HRF in most MNC supernatants. We have overcome this problem by stimulating the cells with histamsne, which inhibits the production of HRF and stimulates the production of HRIF. Additionally, we noticed that HRF activity was easily diluted to insignificant effects at 1:12, whereas HRIF was most active at these dilutions. Another way to separate these cytokines is gel chromatography with Sephadex G-50.
It has been well established that histamine has immunomodulatory properties. T and B lymphocytes and monocytes possess both HI and H2 receptors. Histamine stimulates the production of several lymphokines (reviewed by Beer et al.
[181) including the histamine-induced suppressor factor, lymphocyte chemotactic factor, and migration inhibitory factor for lymphocytes. HRIF appears to be distinct from these lymphokines by virtue of its lower Mr, not being a glycoprotein, and insensitivity to heating at 56°C. Above all, the production of histamine-induced suppressor factor, lymphocyte chemotactic factor, and migration inhibitory factor for lymphocytes requires high concentrations of histamine, usually in the range of l0-5 to 10-3 M whereas the optimal range for HRIF synthesis is 10-8 to 10-6 M. We think the low concentration of histamine needed to stimulate synthesis of HRIF bodes well for the physiologic significance of this cytokine. Whether HRIF possesses other biological activities remains to be determined in future studies.
Studies from several laboratories have established that HRF are cytokines that release histamine and leukotrienes from basophils and mast cells (5) (6) (7) (8) (23) (24) (25) (26) (27) (28) (29) (30) (31) (9) . Recently, it has been shown that a HRF-like substance is produced by two-cell human embryo in culture (32) . Although the significance ofthis finding is not clear, it has been speculated that the release of histamine by HRF might favor implantation of the embryo. Since HRF are produced by so many different cell types, we believe they may have considerable biologic importance. Consequently, a specific inhibitor ofHRF might have a major role in regulating the activation of basophils and mast cells.
Production of HRIF by MNC suggests that these cells not only stimulate the function ofbasophils and mast cells but also inhibit their activity. Stimulation of HRIF production by histamine is another example of the negative feedback mechanisms that exist between lymphocytes and histamine containing cells. Lymphocytes produce HRF that activate mast cells and basophils. Histamine released from the target cells stimulates lymphocytes to synthesize HRIF, which, in turn, inhibits further histamine release, and the immunologic homeostasis is restored. We speculate that a fine balance exists between the production of HRF and HRIF in vivo and loss of this balance may contribute to the development of disease.
Some recent data suggest that this concept might be true for asthmatic patients. Relatively large amounts of HRF are produced spontaneously by MNC from asthmatic patients (33) . This spontaneous HRF production highly correlates with the severity of bronchial hyperreactivity (34) and clinical symptoms (35) . HRF-like molecules have been recovered from skin blister fluid during late-phase allergic reactions (36) , and it has been speculated that HRF might be involved in the development of late-phase reactions. The late allergic reaction is now considered the most important factor in the pathogenesis of chronic asthma. Since HRIF specifically inhibits HRF activity, the production of HRIF might represent a protective mechanism against the development of late allergic reactions and by inference, chronic asthma.
Although synthesis of IgE antibody seems to be a necessary condition for initiation of allergic disease, it may not be sufficient. It has been suggested that the synthesis of HRF is an equally important phenomenon in predisposing individuals to atopy (34) (35) (36) (37) (38) . We propose that specific inhibition of HRF by the endogenous cytokine HRIF may be an important physiologic mechanism for regulating basophils and mast cells. HRIF may be one of the major molecules preventing allergic hypersensitivity, and administration of exogenous HRIF might prove useful for reversing allergic reactions.
